LXEO
Lexeo Therapeutics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$4.89
+1.03%Next report
Analyst consensus
- Next report date
- Dec 14, 2026
- EPS estimate
- -$0.33
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.30
- EPS estimate
- -$0.29
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +13.9%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $9.00
- PT range
- $9.00 – $9.00
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 14, 2026